Current Neuro-Oncology
Volume
14 Number 2
29 February 2012
Home > Publications > Current Neuro-Oncology > Volume 14, Year 2012 > Number 2, 29 February
Pei
Y, Moore CE, Wang J, Tewari AK, Eroshkin A, Cho YJ, Witt H,
Korshunov A, Read TA, Sun JL, Schmitt EM, Miller CR, Buckley AF,
McLendon RE, Westbrook TF, Northcott PA, Taylor MD, Pfister SM,
Febbo PG, Wechsler-Reya RJ.
An
animal model of MYC-driven medulloblastoma.
Cancer
Cell. 2012 Feb 14;21(2):155-67🡥.
doi: 10.1016/j.ccr.2011.12.021🡥.
PMID: 22340590🡥.
Laboratory investigation. 🡥
Turcan
S, Rohle D, Goenka A, Walsh LA, Fang F, Yilmaz E, Campos C, Fabius
AW, Lu C, Ward PS, Thompson CB, Kaufman A, Guryanova O, Levine R,
Heguy A, Viale A, Morris LG, Huse JT, Mellinghoff IK, Chan TA.
IDH1
mutation is sufficient to establish the glioma hypermethylator
phenotype.
Nature.
2012 Feb 15;483(7390):479-83🡥.
doi: 10.1038/nature10866🡥.
PMID: 22343889🡥.
Laboratory investigation. 🡥
Wu
X, Northcott PA, Dubuc A, Dupuy AJ, Shih DJ, Witt H, Croul S,
Bouffet E, Fults DW, Eberhart CG, Garzia L, Van Meter T, Zagzag D,
Jabado N, Schwartzentruber J, Majewski J, Scheetz TE, Pfister SM,
Korshunov A, Li XN, Scherer SW, Cho YJ, Akagi K, MacDonald TJ,
Koster J, McCabe MG, Sarver AL, Collins VP, Weiss WA, Largaespada
DA, Collier LS, Taylor MD.
Clonal
selection drives genetic divergence of metastatic
medulloblastoma.
Nature.
2012 Feb 15;482(7386):529-33🡥.
doi: 10.1038/nature10825🡥.
PMID: 22343890🡥.
Laboratory investigation. 🡥
Massimino
M, Cefalo G, Riva D, Biassoni V, Spreafico F, Pecori E, Poggi G,
Collini P, Pollo B, Valentini L, Potepan P, Seregni E, Casanova M,
Ferrari A, Luksch R, Polastri D, Terenziani M, Pallotti F, Clerici
CA, Schiavello E, Simonetti F, Meazza C, Catania S, Podda M,
Gandola L.
Long-term results of combined preradiation
chemotherapy and age-tailored radiotherapy doses for childhood
medulloblastoma.
J
Neurooncol.
2012 Feb 16. 2012;108(1):163-71. doi: 10.1007/s11060-012-0822-7.
Similar
articles.
Retrospective
analysis.
_
Pietilä
S, Korpela R, Lenko HL, Haapasalo H, Alalantela R, Nieminen P,
Koivisto AM, Mäkipernaa A.
Neurological
outcome of childhood brain tumor survivors.
J
Neurooncol. 2012 Feb 19. 2012;108(1):153-61. doi:
10.1007/s11060-012-0816-5⍈.
PMID: 22350432⍈.
Clinical study. ⍈
Niyazi
M, Söhn M, Schwarz SB, Lang P, Belka C, Ganswindt U.
Radiation
treatment parameters for re-irradiation of malignant
glioma.
Strahlenther
Onkol. 2012 Feb 22. 2012;188(4):328-33. doi:
10.1007/s00066-011-0055-2⍈.
PMID:
22349710⍈.
Retrospective
analysis. ⍈
Kool
M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA,
Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford
SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP,
Bäcklund ML, Haberler C, Bourdeaut F, Delattre O, Doz F,
Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P,
Pfister SM.
Molecular
subgroups of medulloblastoma: an international meta-analysis of
transcriptome, genetic aberrations, and clinical data of WNT, SHH,
Group 3, and Group 4 medulloblastomas.
Acta
Neuropathol. 2012 Feb 23;123(4):473-84🡥.
doi: 10.1007/s00401-012-0958-8🡥.
PMID: 22358457🡥.
Meta-analysis. 🡥